Innoviva (INVA) Acquisitions (2022)
Innoviva (INVA) posted Acquisitions of $23.1 million for Q3 2022, little changed on a QoQ basis from $23.1 million in Q1 2022.
Innoviva (INVA) Acquisitions (2022) Analysis & Trends
Innoviva's Acquisitions history runs 1 years deep, the most recent figure standing at $23.1 million for Q3 2022.
- Quarterly Acquisitions changed N/A year-over-year to $23.1 million in Q3 2022, while the trailing twelve-month figure through Sep 2023 was $23.1 million (down 50.0% YoY) and the FY2022 annual result came in at $23.1 million, changed N/A from the prior year.
- Acquisitions was $23.1 million for Q3 2022 at Innoviva, roughly flat from $23.1 million in the prior quarter.
- Across five years, Acquisitions topped out at $23.1 million in Q1 2022 and bottomed at $23.1 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 23.07 Mn |
| Mar 31, 2022 | 23.07 Mn |